Percutaneous ankaferd injection to in vivo liver tissue in comparison to ethanol in an experimental rat model

Tas, Adnan; Koklu, Seyfettin; Beyazit, Yavuz; Karaca, Gokhan; Astarci, H.; Akbal, Erdem; Kocak, Erdem; Topcu, Goler; HAZNEDAROĞLU, İBRAHİM

doi:10.1016/j.clinre.2011.02.013

Percutaneous ankaferd injection to in vivo liver tissue in comparison to ethanol in an experimental rat model

Atıf İçin Kopyala

Tas A., Koklu S., Beyazit Y., Karaca G., Astarci H. M., Akbal E., ...Daha Fazla

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, cilt.35, ss.549-553, 2011 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 35
Basım Tarihi: 2011
Doi Numarası: 10.1016/j.clinre.2011.02.013
Dergi Adı: CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.549-553
Hacettepe Üniversitesi Adresli: Evet

Özet

Aim: Percutaneous ethanol injection is an established management of nonresectable hepatocellular carcinoma (HCC) because of its high effectiveness and minimal invasiveness. However, ethanol has many disadvantages like less anti-tumoral necrotic effectivity, unequal permeation and local diffusion. The aim of this study is to compare hepatic tissue effects of percutaneous Ankaferd Blood Stopper (ABS) injection in comparison to ethanol in rat liver tissue.